Skip to main content

Fiscal Wizard · Single-issue tearsheet

GENB / Jun 21, 2026 Run #7554

GENB

Generate Biomedicines, Inc.

Generate Biomedicines, Inc., engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics in the United States. It uses protein-based modalities for drug development. Its product includes GB-0895, is an investigational long-acting anti-TSLP monoclonal antibody in development for severe asthma that is intended to be dosed every six months; GB-4362, an MMAE payload neutralizer monoclonal antibody; GB-5267, A MUC16 CAR-T Cell therapy. In additional, it develops Generate Platform, designed to be a therapeutic area and protein modality agnostic system integrating computational innovation with scalable biohardware to address therapeutic challenges beyond the reach of traditional technologies. Generate Biomedicines, Inc. was formerly known as Generate Biologics, Inc. and changed its name to Generate Biomedicines, Inc. in February 2020. The company was incorporated in 2018 and is based in Somerville, Massachusetts.

Composite verdict

F 13.4 / 100
Bearish setup · Trend Following 9 drivers · 2 gates blocking
  • Parabolic SAR Flip
  • Accumulation/Distribution Line
  • TRIX Zero-Line
Consider long put target Δ ~0.70 · ~35 DTE Bearish setup, Grade A → ITM put target

Industry rank 387th of 598 in Biotechnology

rescore-sweep
Technical synthesis
Bull 0%Evidence: High · 13 signals100% Bear
Momentum Bearish 1Mean-reversion Neutral 50

No notable composite patterns — the signals don't cluster into a named setup right now.

Where value comes from

Earnings power doesn't cover the capital structure (high debt) — the EPV decomposition isn't meaningful for this name.

Fundamentals Weak

26.0 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 35 metrics shown.

Strongest
Weakest
Days Sales Outstanding 100
Free Cash Flow Yield 0
P/B 75
P/S Ratio 25
EV/Sales 25

Technicals Bearish

0.8 / 100

Bearish setup leads (Parabolic SAR Flip, Accumulation/Distribution Line, TRIX Zero-Line); bulls gated by guards. · 43 signals shown.

Strongest
Weakest
Parabolic SAR Flip 12
Accumulation/Distribution Line 13
TRIX Zero-Line 19

Risk Gates

2 blocking 3 caution

2 guards active, 16 signals gated.

Altman Z-Score Blocking

Bottom-band Altman Z blocks bullish signals — distress risk.

ADX Trend Weakness Blocking

Weak trend strength blocks trend-following signals in either direction.

Cash Ratio Caution

Visual cash-cushion flag — does not mute signals.

Sloan Ratio Caution

Visual accruals-quality flag — does not mute signals.

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for GENB.